CCM
GOSS icon

CAAS Capital Management’s Gossamer Bio GOSS Stock Holding History

CAAS Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-183,684
Closed -$1.78M – 1262
2020
Q4 		$1.78M Buy
+183,684
New +$1.81M 0.02% 512

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

CAAS Capital Management's GOSS Position: Q1 2021 in Review

CAAS Capital Management sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 183,684 shares — an estimated $1.78M sold.

CAAS Capital Management first reported a position in GOSS in Q4 2020 and held it in 1 quarter. The position peaked at $1.78M in Q4 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • CAAS Capital Management reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 183,684 Gossamer Bio shares in Q1 2021, an estimated $1.78M.
  • CAAS Capital Management first reported a position in Gossamer Bio in Q4 2020 and held it in 1 quarter.
  • CAAS Capital Management's Gossamer Bio position peaked at $1.78M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.